Poland - Miscellaneous medicinal products

Description

Dacarbazine-pharmaceutical form, dose, required quantity is specified in Annex 4.1 AquaCitabine-pharmaceutical form, dose, required quantity is specified in Annex 4.2 AquaCitabine-pharmaceutical form, dose, required quantity is specified in Annex 4.2 AquaCitabine-pharmaceutical form, dose, required quantity is specified in Annex 4.3 SIWZ Narcotic drugs and psychotropic pharmaceutical form, dose, required quantity are specified in Annex 4.4 SIWZ Fentanyl - pharmaceutical form, dose, required quantity are specified in Annex 4.5 SIWZ Cardiovascular system - pharmaceutical form, dose, required quantity are specified in Annex 4.6 SIWZ Medicines used in the infection - pharmaceutical form, dose, required quantity are specified in Annex 4.7 SIWZ Gastrointestinal tract and metabolism - pharmaceutical form, dose, required quantity are specified in Annex 4.8 SIWZ Miscellaneous medicines I - pharmaceutical form, dose, required quantity are specified in Annex 4.9 SIWZ Miscellaneous medicines II - pharmaceutical form, dose, required quantity is specified in Annex 4.10 SIWZ Miscellaneous medicines III - pharmaceutical form, dose, required quantity is specified in Annex 4.11 SIWZ Miscellaneous medicines IV - pharmaceutical form, dose, required quantity is specified in Annex 4.12 SIWZ Miscellaneous medicines V - pharmaceutical form, dose, required quantity is specified in Annex 4.13 SIWZ Miscellaneous medicines VI - pharmaceutical form, dose, required quantity is specified in Annex 4.14 SIWZ Miscellaneous medicines VII - pharmaceutical form, dose, required quantity is specified in Annex 4.15 SIWZ Miscellaneous medicines VIII - pharmaceutical form, dose, required quantity is specified in Annex 4.16 SIWZ Miscellaneous medicines IX - pharmaceutical form, dose, required quantity is specified in Annex 4.17 SIWZ Central nervous system - pharmaceutical form, dose, required quantity is specified in Annex 4.18 SIWZ Ophthalmic medicinal products pharmaceutical form, dose, required amount are specified in Annex 4.19 SIWZ Hormones and vitamins - pharmaceutical form, dose, required amount are specified in Annex 4.20 SIWZ Contrasting preparations I - pharmaceutical form, dose, required amount are specified in Annex 4.21 SIWZ Contrasting preparations II - pharmaceutical form, dose, required quantity are specified in Annex 4.22 SIWZ Mitoxantron - pharmaceutical form, dose, required quantity are specified in Annex 4.23 SIWZ Imatinib - pharmaceutical form, dose, required quantity are specified in Annex 4.The 24SIWZ Infliximab pharmaceutical form, dose, required quantity are specified in Annex 4.25SIWZ Trastuzumab I pharmaceutical form, dose, required quantity are specified in Annex 4.26SIWZ Trastuzumab II pharmaceutical form, dose, required quantity are specified in Annex 4.27SIWZZ Vinorelbinum I - pharmaceutical form, dose, required quantity is specified in Annex 4.28SIWZ Vinorelbinum II - pharmaceutical form, dose, required quantity is specified in Annex 4.29SIWZ Nivolumab - pharmaceutical form, dose, required quantity is specified in Annex 4.30SIWZ Panitumab- pharmaceutical form, dose, required quantity is specified in Annex 4.31SIWZZ Allergen I- pharmaceutical form, dose, required quantity is specified in Annex 4.32 SIWZ Allergen II- pharmaceutical form, dose, required quantity is specified in Annex 4.33 SIWZ Allergen III- pharmaceutical form, dose, required quantity is specified in Annex 4.34 SIWZ Filgrastim - pharmaceutical form, dose, required quantity is specified in Annex 4.35 SIWZ Respiratory system - pharmaceutical form, dose, required quantity is specified in Annex 4.36 SIWZ Amphoterycin B - pharmaceutical form, dose, required quantity is specified in Annex 4.37 SIWZ Surfactam- pharmaceutical form, dose, required quantity is specified in Annex 4.38 SIWZ Omalizumab- pharmaceutical form, dose, required quantity is specified in Annex 4.39 SIWZ Carbetocin- pharmaceutical form, dose, required quantity is specified in Annex 4.40 SIWZ Target import - pharmaceutical form, dose, required quantity is specified in Annex 4.41 SIWZ Dexmedetomidine - pharmaceutical form, dose, required quantity is specified in Annex 4.42 SIWZ Calcium gluconate - pharmaceutical form, dose, required quantity is specified in Annex 4.43 SIWZ Abciximax- pharmaceutical form, dose, required quantity is specified in Annex 4.44 SIWZ Anticancer and immunomodulating drugs - pharmaceutical form, dose, required quantity is specified in Annex 4.45 SIWZ Urogenital system and sex hormones - pharmaceutical form, dose, required quantity is specified in Annex 4.46 SIWZ Nimodypine - pharmaceutical form, dose, required quantity is specified in Annex 4.47 SIWZ Sevoflurane - pharmaceutical form, dose, required quantity is specified in Annex 4.48 SIWZ Gentamycin - pharmaceutical form, dose, required quantity is specified in Annex 4.49 SIWZ Thiopental - pharmaceutical form, dose, required quantity is specified in Annex 4.50 SIWZ Urapidilum - pharmaceutical form, dose, required quantity is specified in Annex 4.51 SIWZ Cefuroxime I - pharmaceutical form, dose, required quantity is specified in Annex 4.52 SIWZ Cefuroxime II- pharmaceutical form, dose, required quantity is specified in Annex 4.53SIWZ Amikacinum- pharmaceutical form, dose, required quantity is specified in Annex 4.54 SIWZ Ribociqlib- pharmaceutical form, dose, required quantity is specified in Annex 4.55 SIWZ Palbociclib- pharmaceutical form, dose, required quantity is specified in Annex 4.56 SIWZ Metamizolum - pharmaceutical form, dose, required quantity is specified in Annex 4.57 SIWZ Tramadol - pharmaceutical form, dose, required quantity is specified in Annex 4.58 SIWZ Norephinephrin - pharmaceutical form, dose, required quantity is specified in Annex 4.59 SIWZ Ceftriaxon- pharmaceutical form, dose, required quantity is specified in Annex 4.60 SIWZ Dimethyl fumarate- pharmaceutical form, dose, required quantity is specified in Annex 4.61 SIWZ Calcium chloride pharmaceutical form, dose, required quantity is specified in Annex 4.62 SIWZ Potassium chloride - pharmaceutical form, dose, required quantity is specified in Annex 4.63 SIWZ Paracetamolum - pharmaceutical form, dose, required quantity is specified in Annex 4.64 SIWZ Amoxicillinum - pharmaceutical form, dose, required quantity is specified in Annex 4.65 SIWZ Colistimethate sodium - pharmaceutical form, dose, required quantity is specified in Annex 4.66 SIWZ Dexamethasone sodium phosphate - pharmaceutical form, dose, required quantity is specified in Annex 4.67 SIWZ Hydrocortison, Lignocainum, Ambroxol - pharmaceutical form, dose, required quantity is specified in Annex 4.68 SIWZ Tissue adhesive - pharmaceutical form, dose, required quantity is specified in Annex 4.69 SIWZ Prothrombinum multiplex humanum - pharmaceutical form, dose, required quantity is specified in Annex 4.70 SIWZ Prothrombinum - pharmaceutical form, dose, required quantity is specified in Annex 4.71SIWZ Umeclidinium + Vilanterol - pharmaceutical form, dose, required quantity is specified in Annex 4.72SIWZ Netupitant + Palonosetron - pharmaceutical form, dose, required quantity is specified in Annex 4.73SIWZ Pertuzumab - pharmaceutical form, dose, required quantity is specified in Annex 4.74SIWZ Teriflunomide- pharmaceutical form, dose, required quantity is specified in Annex 4.75SIWZ Entecavir- pharmaceutical form, dose, required quantity is specified in Annex 4.76 SIWZ Sugammadex- pharmaceutical form, dose, required quantity is specified in Annex 4.77 SIWZ Lanreotide- pharmaceutical form, dose, required quantity is specified in Annex 4.78 SIWZ Immunoglobulinum anti D I- pharmaceutical form, dose, required quantity is specified in Annex 4.79 SIWZ Immunoglobulinum anti D II- pharmaceutical form, dose, required quantity is specified in Annex 4.80 SIWZ Immunoglobulinum anti D III - pharmaceutical form, dose, required quantity is specified in Annex 4.81 SIWZ Fingolimod - pharmaceutical form, dose, required quantity is specified in Annex 4.82 SIWZ Alectynib - pharmaceutical form, dose, required quantity is specified in Annex 4.83 SIWZ Natalizumab - pharmaceutical form, dose, required quantity is specified in Annex 4.84 SIWZ Peginterferon BETA 1-A - pharmaceutical form, dose, required quantity is specified in Annex 4.85 SIWZ Infusion fluids I - pharmaceutical form, dose, required quantity is specified in Annex 4.86 SIWZ Infusion fluids II - pharmaceutical form, dose, required quantity is specified in Annex 4.87 SIWZ Theophylinum - pharmaceutical form, dose, required quantity is specified in Annex 4.88 SIWZ Mepolizumab - pharmaceutical form, dose, required quantity is specified in Annex 4.89SIWZ Parenteral formulae I - pharmaceutical formulae, dose, required quantity are specified in Annex 4.90SIWZ Parenteral formulae II - pharmaceutical formulae, dose, required quantity are specified in Annex 4.91SIWZ Parenteral formulae I - pharmaceutical formulae, dose, required quantity are specified in Annex 4.Irrigation solution - pharmaceutical form, dose, required quantity is specified in Annex 4.94 Irrigation solution - pharmaceutical form, dose, required quantity is specified in Annex 4.94 Irrigation solution - pharmaceutical form, dose, required quantity is specified in Annex 4.94 Irrigation solution Kalium chloratum - pharmaceutical form, dose, required quantity is specified in Annex 4.95 SIWZ Misoprostol - pharmaceutical form, dose, required quantity is specified in Annex 4.96 SIWZ Afatinib - pharmaceutical form, dose, required quantity is specified in Annex 4.97 SIWZ Skeletal-muscular system - pharmaceutical form, dose, required quantity is specified in Annex 4.98 SIWZ

Opportunity closing date

13 December 2019

Value of contract

to be confirmed